• DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic Preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
DNDi - Best Science for the Most Neglected 20 Years
  • DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic Preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

DNDi awarded the Innovation Prize 2017 in Geneva for working to help the most neglected

Home > News

DNDi awarded the Innovation Prize 2017 in Geneva for working to help the most neglected

From left to right: Juan Carlos Torres, President, CCIG, Fréderique Reeb-Landry, Director General, CCIG, Michel Balestra, President of the Jury, Bernard Pécoul, Executive Director, DNDi
10 Nov 2017
Share on twitter
Share on facebook
Share on linkedin
Share on email
Share on print

As part of the ‘Evénement économique 2017’ that took place on November 9, the Geneva Chamber of Commerce, Industry and Services (CCIG), the Department of Security and Economy (DSE) and the Office for the Promotion of Industries and Technologies (OPI) awarded the Innovation Prize 2017 to the Drugs for Neglected Diseases initiative (DNDi).
[Français]

The prize was awarded in recognition of DNDi’s innovative and collaborative model, as well as the progress DNDi has made in medical innovation for neglected patients. Since its creation in 2003, DNDi has already developed and implemented seven treatments against malaria, sleeping sickness, visceral leishmaniasis, Chagas disease, and paediatric HIV. DNDi’s portfolio also includes 16 new chemical entities, some of which could be future new medicines to treat neglected diseases and change the lives of patients and healthcare workers.

“We are very honoured to receive this Innovation Prize here in Geneva, where it all began for DNDi almost 15 years ago,” said Dr Bernard Pécoul, DNDi’s Executive Director. “Innovation is essential when the mission is to develop new treatments for patients who do not represent a profitable market. We had to be innovative to bring together public and private partners into our collaborative model. We will have to continue to be innovative to meet our objectives: developing oral, safe, and effective treatments that are affordable and adapted to field conditions, which are sometimes challenging, in countries where health systems remain fragile. Since innovation is not possible in isolation, we are happy to share this Prize with all of our partners and donors, in Switzerland and around the world”.

Watch an interview with Dr Bernard Pécoul about the Prize (in French)

To support DNDi’s work: www.dndi.org/donate or contact Caroline Gaere: cgaere@dndi.org

For media: media@dndi.org

 

Photo credits: G. Maillot/point-of-views.ch

 

Policy advocacy Partnership

Read, watch, share

Loading...
People entering the Mycetoma Research Centre
Videos
23 Nov 2023

Mycetoma: Neglected but not Forgotten

Nurse caring for patient with a lesion on the feet
Press releases
23 Nov 2023

World’s first clinical trial for devastating fungal disease mycetoma shows efficacy of new, promising treatment

People standing under tents at the Run for Neglected Patients
News
23 Nov 2023

DNDi@20 charity run shines the spotlight on neglected diseases in Kenya

Viewpoints
11 Nov 2023

DNDi: 20 years of delivering treatments for neglected patients

MSF Access Campaign Blog
Statements
7 Nov 2023

Seventh meeting of the Intergovernmental Negotiating Body (INB) for a WHO instrument on pandemic prevention, preparedness and response

Dr James Orbinski, former President of the MSF International Council, accepting the 1999 Nobel Peace Prize on behalf of Médecins Sans Frontières in Oslo, Norway on 10 December 1999
News
30 Oct 2023

MSF uses 1999 Nobel Peace Prize to help found pioneering not-for-profit drug development organization

Out of the Shadows Film Poster
Videos
23 Oct 2023

Out of the Shadows: The Story of DNDi

Dr Luis Pizarro at the Ceremony of the Princess Asturias Awards 2023
News
20 Oct 2023

Acceptance address, Dr Luis Pizarro – 2023 Princess of Asturias Awards Ceremony

VIEW ALL

Help neglected patients

To date, we have delivered twelve new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
DNDi - Best Science for the Most Neglected 20 Years
Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License